[Therapeutic advances in refractory epilepsies in children]

Area of Science:

• Pediatric Neurology
• Epileptology
• Clinical Therapeutics

Background:

• Epilepsy affects thousands of children in Switzerland.
• A significant proportion of pediatric epilepsy cases are refractory to conventional antiepileptic drugs.
• New antiepileptic drug development has not substantially reduced the prevalence of pharmacoresistant epilepsy.

Observation:

• This article presents three pediatric cases with diverse forms of pharmacoresistant epilepsy.
• These children underwent management with either immunomodulatory or neurosurgical interventions.
• The study highlights the clinical application of these advanced therapeutic strategies.

Findings:

• Immunomodulatory therapies offer an alternative for specific pediatric epilepsy syndromes.
• Neurosurgical interventions can be effective in selected cases of drug-resistant epilepsy.
• These alternative approaches provide new avenues for managing challenging pediatric epilepsy cases.

Implications:

• Alternative treatments like immunomodulation and neurosurgery are crucial for refractory pediatric epilepsy.
• Further research into these advanced therapies can improve outcomes for children with difficult-to-treat epilepsy.
• This work contributes to the understanding of non-pharmacological management strategies in pediatric epileptology.